Collecting local data, safety and experience trial.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
280
Ezetimibe 10 mg daily for 42 days.
simvastatin (prescribed clinically suitable dose by the physician), for mean follow up of 42 days.
LDL levels
Time frame: 42 Days
Safety measures
Time frame: 42 days
Total cholesterol levels.
Time frame: 42 Days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.